SCHEMBL24816150

SCHEMBL24816150

COC(=O)c1ccc2c(c1)CN(C(=O)CSc1nccs1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 5/20 0.42
▸ ALDH1A1 P00352 5/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ DCUN1D1 Q96GG9 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ACACB O00763 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ MAPK10 P53779 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986867 1.00 NAMPT (0.42) NAMPTALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL24815708 0.85 ALDH1A1 (0.43) NAMPTALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL26845894 0.84 ALDH1A1 (0.41) NAMPTALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL24814435 0.82 HSD17B3 (0.43) ALDH1A1SMN1; SMN2KDM4EMAPTKMT2A
SCHEMBL24815709 0.81 NAMPT (0.44) NAMPTALDH1A1SMN1; SMN2RAB9AKMT2A
SCHEMBL24815712 0.81 MAOB (0.41) NAMPTALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL29986261 0.81 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EMAPTRAB9A
SCHEMBL24814434 0.81 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EMAPTRAB9A
SCHEMBL24816166 0.79 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2KDM4EMAPTHPGD
SCHEMBL24815667 0.79 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2KDM4ERAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH NAMPT 2850/4885ALDH1A1 3533/4885SMN1; SMN2 1176/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NAMPT 2850/4885ALDH1A1 3533/4885SMN1; SMN2 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback